Jeffrey M. Gidday

Mouse models of retinal ischemic tolerance.

Ischemia-reperfusion injury of retinal endothelium by cyclooxygenase- and xanthine oxidase-derived superoxide.

Cerebrovascular inflammation after brief episodic hypoxia: modulation by neuronal and endothelial nitric oxide synthase.

Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b.

Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation.

Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.

Constitutive nitric oxide synthase activity is required to trigger ischemic tolerance in mouse retina.

Multi-germ layer lineage central nervous system repair: nerve and vascular cell generation by embryonic stem cells transplanted in the injured brain.

Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice.

Cerebral preconditioning and ischaemic tolerance.

Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation.

Long-term tolerance to retinal ischemia by repetitive hypoxic preconditioning: role of HIF-1alpha and heme oxygenase-1.

Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Neutrophil elastase and neurovascular injury following focal stroke and reperfusion.

Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase 2.

Erythropoietin and prenatal hypoxia-ischemia.

Pharmacologic preconditioning: translating the promise.

Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.

Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Junctional protein regulation by sphingosine kinase 2 contributes to blood-brain barrier protection in hypoxic preconditioning-induced cerebral ischemic tolerance.

CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke.

Glaucoma-induced degeneration of retinal ganglion cells prevented by hypoxic preconditioning: a model of glaucoma tolerance.

Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.

Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.

Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.

Enhanced retinal ganglion cell survival in glaucoma by hypoxic postconditioning after disease onset.

Extending injury- and disease-resistant CNS phenotypes by repetitive epigenetic conditioning.

Remote Limb Ischemic Conditioning Enhances Motor Learning in Healthy Humans.

HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage.